author-photo

B. Venugopal

Beatson West of Scotland Cancer Centre

6

Papers

86

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

1234 POSTER A First in Man Phase 1 Study of JNJ-26481585, a Novel Oral Histone Deacetylase Inhibitor (HDACi) in Advanced Cancer Patients -Evidence of Target Modulation, Antitumour Activity and Additional Safety Data in an Expanded Patient Cohort

2011 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Abstract A164: Cardiac effects in a first-in-human (FIH), pharmacokinetic (PK), pharmacodynamic (PD) phase I trial of JNJ-26481585, a second-generation oral hydroxamate histone deacetylase inhibitor (HDACi), in patients with refractory cancer.

2011 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (0)
How to integrate biologicals in the continuum of care

2009 European Journal of Cancer
- B. Venugopal
- Jim Cassidy
Show All
- Source
- Cite
- Save
Citations (1)